product vials

Product Portfolio

Our portfolio includes more than 24 specialized products aimed at providing innovative treatments for unmet medical needs worldwide.

The list below includes our products marketed in the United States. Many of these, as well as other Sanofi Genzyme products, are also approved and marketed in other parts of the world.

Contact Sanofi Genzyme in your region if you are outside the U.S. and want to learn about products available in your area.

Alprolix logo
Alprolix® [Coagulation Factor IX (Recombinant), Fc Fusion Protein]
Cerezyme logo
Cerezyme® (imiglucerase for injection)
Clolar logo
Clolar® (clofarabine injection)
Eloctate logo
Eloctate® [Antihemophilic Factor (Recombinant), Fc Fusion Protein]
sarclisa product logo
Sarclisa® (isatuxamab-irfc) injection for Intravenous Use
Zaltrap logo
ZALTRAP® (ziv-aflibercept) injection for intravenous infusion
Scientist in the lab
What’s in the pipeline?
New product candidates and advances in technology are featured in our product pipeline, which highlights our key research from early stage programs to phase 3 clinical trials.

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies.